Kenneth Krogulski - 14 Apr 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
14 Apr 2022
Transactions value $
$2,791
Form type
4
Filing time
06 May 2022, 17:05:12 UTC
Previous filing
29 Apr 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $255 +94 +0.05% $2.71 184,235 16 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $247 +94 +0.05% $2.63 184,329 18 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $253 +94 +0.05% $2.69 184,423 19 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $258 +94 +0.05% $2.74 184,517 20 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $258 +94 +0.05% $2.75 184,611 21 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $257 +94 +0.05% $2.73 184,705 22 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $265 +101 +0.05% $2.62 184,806 25 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $256 +101 +0.05% $2.53 184,907 26 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $243 +101 +0.05% $2.41 185,008 27 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $254 +101 +0.05% $2.51 185,109 28 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $246 +101 +0.05% $2.44 185,210 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.